Cheiron Raises $8M to Launch AI-Native the Operating System for Drug Programs

Cheiron Secures $8M to Unify Drug Development Data on AI Platform

Palo Alto, Calif.-based Cheiron has raised $8 million in seed funding in a round led by Menlo Ventures, a vote of confidence for a startup betting that drug development needs a single software layer rather than a patchwork of documents and spreadsheets. The company said the capital will help expand its AI-native platform, which is built to organize the full lifecycle of a drug program into one connected, auditable system. Cheiron says its softwa…

A Unified OS for Drug Development: Our Investment in Cheiron

Drug development is one of the hardest problems in the world. It takes a decade, costs billions, and fails 90% of the time. Much of this is a natural consequence of how complex these programs are. A drug in development touches clinical, regulatory, manufacturing, and commercial functions all at once, generating knowledge across each that rarely makes its way into a single shared picture. Even the most talented scientists and program leads end up…

Cheiron Raises $8M Seed Led by Menlo Ventures to Build the Operating System for Drug Programs

Open the article to view the coverage from dailyguardian.ca

Cheiron Raises $8M to Launch AI-Native the Operating System for Drug Programs

What You Should Know AI-native life sciences platform Cheiron has secured $8M in seed funding led by Menlo Ventures, with Venky Ganesan joining the board.Strategic backers include Moderna co-founder Robert Langer, former Pfizer CMO Freda Lewis-Hall, Chai Discovery CEO Josh Meier, former Starbucks CEO Laxman Narasimhan, and former Apple AI chief John Giannandrea.Cheiron is designed to replace fragmented spreadsheets, papers, and filings by repres…